Literature DB >> 9084845

Sentinel lymph node uptake of two different technetium-labeled radiocolloids,.

S D Nathanson1, P Anaya, K C Karvelis, L Eck, S Havstad.   

Abstract

BACKGROUND: The study was designed to compare the uptake of technetium-99m-labeled human serum albumin ([99mTc]HSA) and 99mtechnetium-labeled sulfur colloid ([99mTc]SC) in the sentinel lymph nodes (SLNs).
METHODS: Radiocolloid levels in the SLN, femoral lymph node (FLN), ischial lymph node (ILN), spleen (SP), and right rear footpad (RRF) were quantitated over a period of 240 min after injection of [99mTc]SC or [99mTc]HSA into the rear footpad of C57 BL/6 mice.
RESULTS: There was a significantly greater (p < 0.001) radioactive count in SLNs after [99mTc]SC (mean cpm 211,084.8) compared to [99mTc]HSA (mean cpm 115,640.8). In contrast, the counts in the FLNs were higher after [99mTc]HSA (mean cpm 11,333.4) than after [99mTc]SC injection (mean cpm 5,065.5). The percent uptake in the SP was higher after [99mTc]HSA than after [99mTc]SC injection.
CONCLUSIONS: [99mTc]SC is rapidly and efficiently taken up by lymphatics at the primary injection site, is significantly retained in the SLN, and flows slowly to the next echelon node (FLN or ILN) and to the systemic circulation (SP). [99mTc]HSA tends to accumulate less efficiently in the SLN and to disperse more rapidly to the next echelon nodes and to the systemic circulation. By extrapolation, [99mTc]SC is likely to be a better radiocolloid for the intraoperative detection of SLNs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9084845     DOI: 10.1007/bf02303791

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  4 in total

1.  A phase I/II trial of 125I methylene blue for one-stage sentinel lymph node biopsy.

Authors:  Jason David Cundiff; Yi-Zarn Wang; Gregory Espenan; Thomas Maloney; Arthur Camp; Laura Lazarus; Alan Stolier; Randy Brooks; Bruce Torrance; Shawn Stafford; James P O'Leary; Eugene A Woltering
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

2.  Targeted non-covalent self-assembled nanoparticles based on human serum albumin.

Authors:  Anton Bunschoten; Tessa Buckle; Joeri Kuil; Gary D Luker; Kathryn E Luker; Omgo E Nieweg; Fijs W B van Leeuwen
Journal:  Biomaterials       Date:  2011-10-22       Impact factor: 12.479

3.  99mTc-phytate is better than 99mTc-human serum albumin as a radioactive tracer for sentinel lymph node biopsy in breast cancer.

Authors:  Hiroyuki Takei; Kimito Suemasu; Masafumi Kurosumi; Jun Ninomiya; Yoshio Horii; Kenichi Inoue; Toshio Tabei
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

4.  Technetium-99m-labeled rituximab for use as a specific tracer of sentinel lymph node biopsy: a translational research study.

Authors:  Xuejuan Wang; Zhi Yang; Baohe Lin; Yan Zhang; Shizhen Zhai; Qichao Zhao; Qing Xie; Fei Liu; Xuedi Han; Jinfeng Li; Tao Ouyang
Journal:  Oncotarget       Date:  2016-06-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.